
Phantom Neuro implanted its Phantom X neural interface in the first participants of its CYBORG study at Cabrini Health in Melbourne. The device sits beneath the skin over the muscles of a residual limb, detecting signals when users try to move missing fingers or a wrist and converting them into wireless commands for a prosthetic arm. The study plans to enroll 10 people with below-the-elbow amputations. Phantom, which raised a $19M Series A led by Ottobock last year, also announced plans to raise a $30M Series B.